| Literature DB >> 30470757 |
Chao Li1, Yi-Xuan Cao1, Rui Wang1, Yi-Ning Wang1, Quan Lan1, Xi-Sheng Wang2.
Abstract
The selective incorporation of gem-difluoroalkyl groups into biologically active molecules has long been used as an efficient strategy for drug design and discovery. However, the catalytic C(sp3)-CF2 bond-forming cross-coupling reaction for selective incorporation of difluoromethylene group into diverse alkyl chains, especially more sterically demanding secondary and tertiary functionalized alkanes, still remains as a major challenge. Herein, we describe a cobalt-catalyzed difluoroalkylation of tertiary aryl ketones for facile synthesis of quaternary alkyl difluorides, which exhibited high efficiency, broad scope and mild conditions. The synthetic utility of this method is demonstrated by late-stage difluoroalkylation of donepezil, a well-known acetylcholinesterase inhibitor used to treat the Alzheimer's disease. Preliminary mechanistic investigations indicate that a difluoroalkyl radical is involved in a Co(I)/Co(III) catalytic cycle. This cobalt-catalyzed fluoroalkylation thus offers insights into an efficient way for the synthesis of fluoroalkylated bioactive molecules for drug discovery.Entities:
Year: 2018 PMID: 30470757 PMCID: PMC6251884 DOI: 10.1038/s41467-018-07525-y
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Fig. 1Transition-metal-catalyzed cross-coupling for facile synthesis of difluoroalkylated alkanes. a Ni-catalyzed difluoropropargylation of 1° alkylzinc reagents. b Co-catalyzed difluoroalkylation of tertiary aryl ketones
Cobalt-catalyzed difluoroalkylation: optimization of conditionsa
|
|
dppBz = 1,2-bis(diphenylphosphino)benzene
aReaction conditions: 1a (0.2 mmol, 1.0 equiv), 2a (3.0 equiv), [Co] (10 mol%), dppBz (10 mol%), base (105 mol%), Zn (0.5 equiv), solvent (2.0 mL), −10 °C, 12 h, N2
bYields of the isolated products given
cDioxane was used as solvent
dT = −30 °C
eT = 0 °C
Fig. 2Cobalt-catalyzed difluoroalkylation of aryl ketones. a Scope of cyclic ketones. b Scope of acyclic ketones. c Scope of difluoroalkylating reagents. Conditions: 1 (0.2 mmol, 1.0 equiv), 2 (3.0 equiv), CoBr2 (10 mol%), dppBz (10 mol%), LDA (105 mol%), Zn (0.5 equiv), THF (2.0 mL), −10 °C, 12 h, under N2 atmosphere. aConditions: 20 mol% of CoBr2 and 20 mol% of dppBz were used. dppBz = 1,2-bis(diphenylphosphino)benzene
Fig. 3Late-stage difluoroalkylation of biologically active molecules. Conditions: 4 (0.2 mmol, 1.0 equiv), 2 (3.0 equiv), CoBr2 (10 mol%), dppBz (10 mol%), LDA (105 mol%), Zn (0.5 equiv), THF (2.0 mL), −10 °C, 12 h, under N2 atmosphere. dppBz = 1,2-bis(diphenylphosphino)benzene
Fig. 4Mechanistic studies. a Radical trapping experiment with β-piene. b Control experiments using Cobalt(I) complex. c Studies on generation of the difluoroalkyl radical. d Determination of the sequence of transmetallation and activation of fluoroalkyl bromide
Fig. 5Proposed mechanism. The possible reaction pathway based on our studies and the previous literatures